EDWARDS LIFESCIENCES CORPORATION Funds and ETFs Edwards Lifesciences Corporation
Equities
EW
US28176E1082
Advanced Medical Equipment & Technology
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 89.16 USD | -1.06% |
|
+2.81% | +16.92% |
ETFs positioned on Edwards Lifesciences Corporation
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 2.46% | 42 M€ | +2.30% | - | |
| 2.34% | 17 M€ | +7.73% | - | |
| 2.13% | 6 M€ | 0.00% | - | |
| 1.17% | 224 M€ | +4.10% | - | |
| 1.17% | 24 M€ | +0.87% | - | |
| 1.17% | 26 M€ | +1.08% | - | |
| 1.11% | 14 M€ | -3.66% | ||
| 1.06% | 2 M€ | +10.27% | ||
| 0.97% | 1 M€ | +2.21% | - | |
| 0.94% | 4,592 M€ | +11.18% | ||
| 0.89% | 37 M€ | -.--% | ||
| 0.73% | 9 M€ | -.--% | - | |
| 0.52% | 1 M€ | +16.32% | ||
| 0.46% | 2 M€ | +20.44% | - | |
| 0.44% | 5 M€ | -72.95% | - | |
| 0.42% | 3,859 M€ | +18.82% | - | |
| 0.42% | 469 M€ | -2.05% | ||
| 0.36% | 8 M€ | +5.66% | ||
| 0.36% | 2,383 M€ | +13.60% | ||
| 0.34% | 36 M€ | +22.19% | ||
| 0.33% | 50 M€ | +10.93% | ||
| 0.33% | 25 M€ | +5.10% | - | |
| 0.30% | 727 M€ | +9.36% | ||
| 0.30% | 219 M€ | +17.17% | - | |
| 0.30% | 1,448 M€ | -.--% | - | |
| 0.25% | 264 M€ | -.--% | - | |
| 0.24% | 187 M€ | +10.81% | - | |
| 0.24% | 477 M€ | +12.35% | ||
| 0.24% | 330 M€ | -.--% | ||
| 0.23% | 2 M€ | +14.69% | - | |
| 0.23% | 8 M€ | +7.30% | - | |
| 0.23% | 744 M€ | +9.63% | ||
| 0.21% | 276 M€ | +11.40% | - |
Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows:
- heart valves and surgery products (67.9%);
- hemodynamic monitoring systems (15.5%);
- other (16.6%): balloon catheters, artificial implants, etc.
Net sales are distributed geographically as follows: the United States (58.4%), Europe (22.2%), Japan (7.6%) and other (11.8%).
Calendar
2024-07-24
- Q2 2024 Earnings Release (Projected)
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
31
Last Close Price
89.14
USD
Average target price
95.9
USD
Spread / Average Target
+7.59%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +16.92% | 53.72B | |
| +12.15% | 227B | |
| +14.90% | 197B | |
| +18.22% | 141B | |
| +29.15% | 110B | |
| +0.53% | 64.15B | |
| +6.33% | 51.75B | |
| +10.93% | 45.2B | |
| +5.87% | 37.37B | |
| +27.06% | 32.11B |
- Stock Market
- Equities
- EW Stock
- Funds and ETFs Edwards Lifesciences Corporation
